SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.
|
|
|
|
|
1-10 employees
View all SignPath Pharma Inc. employees
|
|
|
Pharmaceutical Manufacturing
|
|
|
9710 Ruskin Cir, Sandy, Utah 84092, US
|
|
|
2006
|
|
|
Pharmaceuticals
|
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.